Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jul;16(Suppl 3):S2854-S2856.
doi: 10.4103/jpbs.jpbs_317_24. Epub 2024 Jul 31.

Ocular Manifestations of Systemic Diseases: Implications for Comprehensive Patient Care

Affiliations

Ocular Manifestations of Systemic Diseases: Implications for Comprehensive Patient Care

Sunil Kumar et al. J Pharm Bioallied Sci. 2024 Jul.

Abstract

Background: Ocular manifestations of systemic diseases pose significant challenges to clinicians due to their diverse presentations and potential impact on vision. Understanding these manifestations is crucial for effective patient management and prevention of vision loss.

Materials and methods: In this prospective clinical study, we investigated ocular manifestations in 50 patients with various systemic diseases, including diabetes mellitus, hypertension, autoimmune disorders, and infectious diseases. Patients underwent comprehensive ocular examinations and systemic evaluations to assess the prevalence and characteristics of ocular complications associated with each systemic condition.

Conclusion: Diabetic retinopathy was the most common ocular manifestation among diabetic patients, while hypertensive retinopathy predominated in hypertensive individuals. Autoimmune disorders were associated with uveitis and retinal vasculitis, whereas infectious diseases presented with ocular infections. Correlation analyses revealed significant associations between systemic parameters and ocular findings, emphasizing the importance of systemic disease control in preventing vision-threatening complications.

Keywords: Diabetic retinopathy; hypertensive retinopathy; interdisciplinary collaboration; ocular infections; ocular manifestations; retinal vasculitis; systemic diseases; uveitis.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

References

    1. Wong TY, Klein R, Islam FMA, Cotch MF, Folsom AR, Klein BEK, et al. Diabetic retinopathy in a multi-ethnic cohort in the United States. Am J Ophthalmol. 2006;141:446–55. - PMC - PubMed
    1. Wong TY, Mitchell P. Hypertensive retinopathy. N Engl J Med. 2004;351:2310–7. - PubMed
    1. Cheung N, Mitchell P, Wong TY. Diabetic retinopathy. Lancet. 2010;376:124–36. - PubMed
    1. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. IV. Diabetic macular edema. Ophthalmology. 1984;91:1464–74. - PubMed
    1. Jabs DA, Nussenblatt RB, Rosenbaum JT Standardization of Uveitis Nomenclature (SUN) Working Group. Standardization of uveitis nomenclature for reporting clinical data. Results of the First International Workshop. Am J Ophthalmol. 2005;140:509–16. - PMC - PubMed

LinkOut - more resources